Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis

Sporadic inclusion-body myositis (sIBM) is the most common disabling, adult-onset, inflammatory myopathy histologically characterized by intense inflammation and vacuolar degeneration. In spite of T cell-mediated cytotoxicity and persistent, clonally expanded and antigen-driven endomysial T cells, t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dalakas, Marinos C., Rakocevic, Goran, Schmidt, Jens, Salajegheh, Mohammad, McElroy, Beverly, Harris-Love, Michael O., Shrader, Joseph A., Levy, Ellen W., Dambrosia, James, Kampen, Robert L., Bruno, David A., Kirk, Allan D.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2009
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2685923/
https://ncbi.nlm.nih.gov/pubmed/19454532
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/awp104
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados